Acupuncture and Herbal Medicine
|
2026, 6(3): 293-297
Traditional Chinese medicine: a promising wholeprocess management for Alzheimer's disease
Full
- 1Department of Neurology, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China
- 2Institute of Brain and Cognitive Disorders, Beijing University of Chinese Medicine, Beijing, China
- 3Beijing Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
Lulu Yao, Jingnian Ni, Mingqing Wei, Ting Li, Fuyao Li, Jing Shi, Jinzhou Tian.
Traditional Chinese medicine: a promising wholeprocess management for Alzheimer's disease[J].
Acupuncture and Herbal Medicine,
2026
, 6
(3)
: 293
-297
.
DOI: 10.1097/HM9.0000000000000209
- State Administration of Traditional Chinese Medicine of the People's Republic of China(DZMG-JBZX-25001)
- Ministry of Science and Technology of the People's Republic of China(2025ZD1801801)
- Strategic Research and Consulting Project of the Chinese Academy of Engineering(2025-PP-15)
- National Key Research Program(2023YFC3504304)
- Decoding Traditional Chinese Medicine collaborative research projects(BZYJMZY-2022-002)
- Fundamental Research Funds for the Central Universities(2026-JYB-XJSJJ043)
[1]
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.
Lancet Public Health 2022;7(2):e105–e125.
[2]
Wimo A, Seeher K, Cataldi R, et al. The worldwide costs of dementia in 2019.
Alzheimers Dement 2023;19(7):2865–2873.
[3]
Jack CR, Therneau TM, Weigand SD, et al. Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging-Alzheimer's Association Research Framework.
JAMA Neurol 2019;76(10):1174–1183.
[4]
Preethy HA, Rajendran K, Sukumar AJ, et al. Emerging paradigms in Alzheimer's therapy.
Eur J Pharmacol 2024;981:176872.
[5]
Golde TE, Levey AI. Immunotherapies for Alzheimer's disease.
Science 2023;382(6676):1242–1244.
[6]
Bellelli F, Angioni D, Arosio B, et al. Hallmarks of aging and Alzheimer's disease pathogenesis: paving the route for new therapeutic targets.
Ageing Res Rev 2025;106:102699.
[7]
Frisoni GB, Aho E, Brayne C, et al. Alzheimer's disease outlook: controversies and future directions.
Lancet 2025;406(10510):1424–1442.
[8]
Liu J, Wang LN, Tian JZ. Recognition of dementia in ancient China.
Neurobiol Aging 2012;33(12):2948.e11–2948.e13.
[9]
Pei H, Ma L, Cao Y, et al. Traditional Chinese medicine for Alzheimer's disease and other cognitive impairment: a review.
Am J Chin Med 2020;48(3):487–511.
[10]
Tian JZ, Shi J, Ni JN, et al. Sequential therapy based on evolvement of patterns: a new model for treatment of Alzheimer's disease.
Chin J Integr Med 2019;25(8):565–573.
[11]
Jack CR, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.
Alzheimers Dement 2024;20(8):5143–5169.
[12]
Pichet Binette A, Smith R, Salvadó G, et al. Evaluation of the revised criteria for biological and clinical staging of Alzheimer disease.
JAMA Neurol 2025;82(7):666–675.
[13]
Tian J, Shi J, Wei M, et al. Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: a 52-week randomized controlled trial.
Alzheimers Dement (N Y) 2019;5:441–449.
[14]
Shi J, Wei M, Ni J, et al. Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial.
J Transl Med 2020;18(1):76.
[15]
Savaskan E, Mueller H, Hoerr R, et al. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials.
Int Psychogeriatr 2018;30(3):285–293.
[16]
Shi J, Ni J, Lu T, et al. Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer's disease: a retrospective analysis.
BMC Complement Altern Med 2017;17(1):533.
[17]
Wang Q, Wang DL, Zhang XC, et al. Efficacy and safety of traditional Chinese medicine and Western medicine in Alzheimer's disease: a systematic review and meta-analysis.
Front Neurol 2025;16:1607945.
[18]
Cui S, Zhao Y, Wang X, et al. Evaluating the clinical evidence of TCM in Alzheimer's disease: an evidence map perspective.
Front Neurol 2025;16:1571361.
[19]
He S, Shi J, Chai H, et al. Mechanisms with network pharmacology approach of Ginsenosides in Alzheimer's disease.
Heliyon 2024;10(5):e26642.
[20]
Tang M, Taghibiglou C. The mechanisms of action of curcumin in Alzheimer's disease.
J Alzheimers Dis 2017;58(4):1003–1016.
[21]
Sun C, Dong S, Chen W, et al. Berberine alleviates Alzheimer's disease by regulating the gut microenvironment, restoring the gut barrier and brain-gut axis balance.
Phytomedicine 2024;129:155624.
[22]
Nie J, Luo Y, Huang X-N, et al. Icariin inhibits beta-amyloid peptide segment 25-35 induced expression of beta-secretase in rat hippocampus.
Eur J Pharmacol 2010;626(2-3):213–218.
[23]
Zhang B, Li Q, Chu X, et al. Salidroside reduces tau hyperphosphorylation
via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer's disease.
Transl Neurodegener 2016;5:21.
[24]
Guo C, Shen J, Meng Z, et al. Neuroprotective effects of polygalacic acid on scopolamine-induced memory deficits in mice.
Phytomedicine 2016;23(2):149–155.
[25]
Lian W, Yuan X, Zhou F, et al. Cornuside ameliorates LPS induced cognitive dysfunction and microglial NLRP3 inflammasome activation by enhancing Sirt1-mediated autophagy.
J Ethnopharmacol 2026;355(Pt A):120615.
[26]
Lu F, Li L, Zheng B, et al. Icariin alleviates cognitive dysfunction by reducing neuroinflammation
via the cGAS-STING pathway.
J Ethnopharmacol 2025;350:120010.
[27]
Huang H, Lu W, Huang Y, et al. Bazi Bushen improves cognitive dysfunction in 5×FAD mice by targeting amyloid pathology, neuroinflammation and cellular senescence.
J Ethnopharmacol 2026;355(Pt A):120586.
[28]
Yao Q, Wu Y, Luo Y. Yuanzi-Shichangpu herb pair ameliorates mitochondrial energetics and restores blood-brain barrier integrity in Alzheimer's disease through the HIF-1α/GSK3β-Nrf2/PGC-1α axis.
J Ethnopharmacol 2026;367:121696.
[29]
Wu W, Meng T, Han L, et al. Bridging traditional Chinese medicine and Alzheimer's disease: the pivotal role of gut microbiota in multitarget therapeutic mechanisms.
Front Pharmacol 2025;16:1630205.
[30]
Zhang J, Zhang B, Fauci AJ, et al. The Rome consensus: good clinical trials for traditional medicine.
Acupunct Herb Med 2025;5(3):271–271.
[31]
Sun D, Chen P, Tao L, et al. Network pharmacology in food-medicine homology: AI-driven decoding of multi-target synergy from molecular networks to precision health.
Acupunct Herb Med 2026;6(1):10–27.
PDF
5
0
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
